鬱および不安ハンドブック(第2版)<br>Handbook of Depression and Anxiety : A Biological Approach, Second Edition (Medical Psychiatry Series) (2ND)

個数:

鬱および不安ハンドブック(第2版)
Handbook of Depression and Anxiety : A Biological Approach, Second Edition (Medical Psychiatry Series) (2ND)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 852 p.
  • 言語 ENG
  • 商品コード 9780824708726
  • DDC分類 616.8527

基本説明

Offers enhanced therapeutic strategies and outcome measures for patient care and management and includes the most recent imaging technologies for improved empirical diagnostic results.

Full Description

Features new to the second edition of this handbook include measurement scales used in research, breakthroughs in pharmacogenomics, epidemiology, genetics, psychophysiology and pharmacology, and enhanced therapeutic strategies and outcome measures for patient care and management.

Contents

A conceptual history of anxiety and depression, Gerrit Glas; epidemiology of depression and anxiety, Borwin Bandelow; comorbidity of depression and anxiety, Giovanni B. Cassano, Nicolo B. Rossi, Stefano Pini; anxiety, depression, and personality, Harald N. Aschauer and Monika Schlogelh; is there a common aetiology for depression and anxiety?, Dean F. MacKinnon and Rudolf Hoehn-Saric; measurements of depression and anxiety disorders, Saena Arbabzadeh-Bouchez and Jean Pierre Lepine; combining psychotherapy and pharmacotherapy for depression and anxiety, Robert H. Howland and Michael E. Thase; genetics of depression, Wolfgang Maier and Kathleen Merikangas; genetics of anxiety, Wolfgang Maier; stress-responsive neuro-hormones in depression and anxiety, Andreas Strohle and Florian Holsboer; neuropeptide alterations in depression and anxiety disorders, David A. Gutman, Dominique L. Musselman, and Charles B. Nemeroff; immunology in anxiety and depression, Norbert Muller and Markus J. Schwarz; brain imaging in depression and anxiety, Peter S. Talbot, Sanjay J. Mathew, and Marc Laruelle; neurobiology of anxiety and depression, Philip T. Ninan and Thomas K. Cummins; intracellular signalling transduction dysregulation in depression and possible future targets for antidepressant therapy - beyond the serotonin hypothesis, Andrea Trentani, S. Kuipers, G.J. Ter Horst, and Johan A. den Boer; norepinephrine in depression and anxiety, Pedro L. Delgado; benzodiazepines, benzodiazepine receptors, and endogenous ligands, Werner Sieghart; antidepressants for the treatment of depression and anxiety disorders - same mechanism of action?, R. Hamish McAllister-Williams and Stephen P. Tyrer; studies on the neurobiology of depression,. Carlos A. Zarate and Dennis S. Charney; animal models of subtypes of depression, Paul Willner and Paul J. Mitchell; pathogenesis of depression - reconsideration of neurotransmitter data by depletion paradigms, Alexander Neumeister and Asastasios Konstantinidis; effects of antidepressants on specific neurotransmitters - are such effects relevant to therapeutic actions?, Brian Leonard; pharmacotherapy of depression - the acute and long-term perspective, Robert J. Boland and Martin B. Keller; pharmacotherapy of bipolar disorder, Kenneth Thau and Anna Maria Steeruwitz; development of new treatment options for depression, Siegfried Kasper and Alan F. Schatzberg; the depressed patient - from nonresponse to complete remission, Koen Demyttenaere and Jurgen DeFruyt. (Part contents).